Acinetobacter baumannii: Its Clinical Significance in Human and Veterinary Medicine

Francesca Paola Nocera1, Anna-Rita Attili2, Luisa De Martino1

  • 1Department of Veterinary Medicine and Animal Production, University of Naples "Federico II", 80137 Naples, Italy.

Insights

Acinetobacter baumannii, a multidrug-resistant pathogen, causes severe hospital infections in humans and animals. Carbapenem-resistant strains are an increasing global concern for both human and veterinary medicine.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter baumannii is a Gram-negative opportunistic pathogen.
  • It is a significant cause of nosocomial infections worldwide.
  • The bacterium exhibits strong environmental adaptability and multi-drug resistance.

Purpose of the Study:

  • To highlight the increasing prevalence of Acinetobacter baumannii infections.
  • To emphasize the challenges posed by multi-drug resistant strains.
  • To address the emerging threat of carbapenem-resistant Acinetobacter baumannii in both human and veterinary medicine.

Main Methods:

  • Literature review of Acinetobacter baumannii infections.
  • Analysis of infection rates and resistance profiles.
  • Examination of clinical and veterinary case reports.

Main Results:

  • Acinetobacter baumannii infections are increasing in human medicine.
  • Multi-drug resistant strains, particularly carbapenem-resistant ones, are a significant clinical problem.
  • Veterinary nosocomial infections associated with Acinetobacter baumannii have been reported.

Conclusions:

  • Acinetobacter baumannii poses a growing threat due to its resistance.
  • Carbapenem-resistant strains represent an emerging opportunistic pathogen in both human and veterinary fields.
  • Effective therapeutic strategies are urgently needed to combat these infections.